Suppr超能文献

中国癌症患者急性肾损伤:一项全国性调查。

Acute kidney injury in cancer patients: A nationwide survey in China.

机构信息

Department of Nephrology, Zhejiang Provincial People's Hospital, Zhejiang, 310014, P. R. China.

People's Hospital of Hangzhou Medical College, Zhejiang, 310014, P. R. China.

出版信息

Sci Rep. 2019 Mar 5;9(1):3540. doi: 10.1038/s41598-019-39735-9.

Abstract

Cancer patients have a high risk for acute kidney injury (AKI); however, the incidence, severity, and risk factors of malignancy-related AKI (MR-AKI) are unclear. This study aimed to assess MR-AKI risk factors and provide reliable data for AKI prevention, diagnosis, and management in China. This cross-sectional study analysed data from 44 academic and local hospitals in China. AKI patients were identified based on 2 screening criteria: the 2012 Kidney Disease: Improving Global Outcomes-AKI definition and the expanded screening criteria for patients with no repeated serum creatinine (SCr) test within 7 days and those who recovered from AKI. Patients whose SCr level increased or decreased by 50% during hospitalization, compared with that at admission, were considered to have AKI according to the expanded criteria. A total of 7,604 AKI patients were enrolled (1,418 with MR-AKI). Patient characteristics were compared between the MR-AKI and non-MR-AKI groups. Multivariate logistic models were used to statistically assess risk factors. The proportions of MR-AKI patients in academic and local hospitals were 20.2% and 14.1%, respectively. The incidence of MR-AKI was higher in mid-China (the affluent region), elderly patients, and groups with higher per capita gross domestic product. Among MR-AKI cases, gastrointestinal cancer (50.1%) was the most common malignancy, followed by cancers of the reproductive (15.3%), haematological (13.1%), respiratory (11.8%), and other systems (8.3%), and cancers of unknown classification (1.4%). Of 268 hospital deaths, respiratory, haematological, gastrointestinal, reproductive, other system, and unknown classification cancers accounted for 29.3%, 18.8%, 18.6%, 12.9%, 16.9%, and 20.0%, respectively. Increased age, advanced AKI stage at peak, level of per capita gross domestic product, geographic region, and renal replacement therapy indication were risk factors for hospital mortality in patients with gastrointestinal MR-AKI, whereas cardiovascular disease history, AKI stage at peak, and geographic region were risk factors for mortality in patients with reproductive MR-AKI. The incidence and mortality of MR-AKI vary by hospital, economic level, age, geographic region, and malignancy type. High MR-AKI incidence was associated with gastrointestinal cancers and higher level of medical care provided by academic hospitals in affluent regions such as Beijing, Shanghai, and other provincial-level cities. Elderly patients with advanced gastrointestinal cancer in mid-China showed the highest incidence of MR-AKI and in-hospital mortality, and thus require special attention.

摘要

癌症患者发生急性肾损伤(AKI)的风险较高;然而,恶性肿瘤相关 AKI(MR-AKI)的发生率、严重程度和危险因素尚不清楚。本研究旨在评估 MR-AKI 的危险因素,为中国 AKI 的预防、诊断和管理提供可靠数据。本横断面研究分析了来自中国 44 家学术和地方医院的数据。AKI 患者的识别基于 2 个筛选标准:2012 年肾脏病:改善全球结局 AKI 定义和无重复血清肌酐(SCr)检测且 AKI 恢复患者的扩展筛选标准,在 7 天内。根据扩展标准,住院期间 SCr 水平增加或减少 50%的患者被认为患有 AKI。根据扩展标准,与入院时相比,住院期间 SCr 水平增加或减少 50%的患者被认为患有 AKI。共纳入 7604 例 AKI 患者(1418 例为 MR-AKI)。比较 MR-AKI 组和非 MR-AKI 组患者的特征。多变量逻辑模型用于统计评估危险因素。学术医院和地方医院的 MR-AKI 患者比例分别为 20.2%和 14.1%。在中国中部(富裕地区)、老年患者和人均国内生产总值较高的人群中,MR-AKI 的发生率较高。在 MR-AKI 病例中,胃肠道癌(50.1%)是最常见的恶性肿瘤,其次是生殖系统(15.3%)、血液系统(13.1%)、呼吸系统(11.8%)和其他系统(8.3%),以及未知分类(1.4%)癌症。在 268 例住院死亡中,呼吸系统、血液系统、胃肠道、生殖系统、其他系统和未知分类癌症分别占 29.3%、18.8%、18.6%、12.9%、16.9%和 20.0%。年龄较大、峰值时 AKI 分期较高、人均国内生产总值、地理区域和肾脏替代治疗指征是胃肠道 MR-AKI 患者住院死亡的危险因素,而心血管疾病史、峰值时 AKI 分期和地理区域是生殖系统 MR-AKI 患者死亡的危险因素。MR-AKI 的发生率和死亡率因医院、经济水平、年龄、地理区域和恶性肿瘤类型而异。高 MR-AKI 发生率与胃肠道癌症有关,并且北京、上海等省级城市等富裕地区的学术医院提供的医疗水平较高。中国中部年龄较大的晚期胃肠道癌老年患者 MR-AKI 发生率和住院死亡率最高,因此需要特别关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/42bc/6401015/8d8e22f83130/41598_2019_39735_Fig1_HTML.jpg

相似文献

1
Acute kidney injury in cancer patients: A nationwide survey in China.
Sci Rep. 2019 Mar 5;9(1):3540. doi: 10.1038/s41598-019-39735-9.
2
Community-Acquired Acute Kidney Injury: A Nationwide Survey in China.
Am J Kidney Dis. 2017 May;69(5):647-657. doi: 10.1053/j.ajkd.2016.10.034. Epub 2017 Jan 20.
3
Acute kidney injury in China: a cross-sectional survey.
Lancet. 2015 Oct 10;386(10002):1465-71. doi: 10.1016/S0140-6736(15)00344-X.
4
Epidemiology and outcomes of acute kidney injury in hospitalized cancer patients in China.
Int J Cancer. 2019 Jun 1;144(11):2644-2650. doi: 10.1002/ijc.31993. Epub 2019 Jan 3.
7
The characteristics and mortality risk factors for acute kidney injury in different age groups in China-a cross sectional study.
Ren Fail. 2016 Oct;38(9):1413-1417. doi: 10.1080/0886022X.2016.1227618. Epub 2016 Oct 19.
8
The impact of transient and persistent acute kidney injury on short-term outcomes in very elderly patients.
Clin Interv Aging. 2017 Jun 28;12:1013-1020. doi: 10.2147/CIA.S135241. eCollection 2017.
9
Vancomycin-induced acute kidney injury in elderly Chinese patients: a single-centre cross-sectional study.
Br J Clin Pharmacol. 2018 Aug;84(8):1706-1718. doi: 10.1111/bcp.13594. Epub 2018 May 24.
10
Acute kidney injury burden in different clinical units: Data from nationwide survey in China.
PLoS One. 2017 Feb 2;12(2):e0171202. doi: 10.1371/journal.pone.0171202. eCollection 2017.

引用本文的文献

1
Acute kidney injury: pathogenesis and therapeutic interventions.
Mol Biomed. 2025 Sep 5;6(1):61. doi: 10.1186/s43556-025-00293-4.
2
The impact of renal dysfunction after critical illness on the management of cancer.
Front Nephrol. 2025 May 22;5:1597253. doi: 10.3389/fneph.2025.1597253. eCollection 2025.
3
Diagnostic potential of CDK1 and STAT1 in acute kidney injury associated with gastrointestinal cancers: a bioinformatics-based study.
Front Mol Biosci. 2025 Jan 22;12:1522246. doi: 10.3389/fmolb.2025.1522246. eCollection 2025.
4
Remote organ cancer induces kidney injury, inflammation, and fibrosis and adversely alters renal function.
Am J Physiol Renal Physiol. 2025 Feb 1;328(2):F272-F288. doi: 10.1152/ajprenal.00264.2024. Epub 2024 Dec 16.
5
Prevalence of kidney disease in patients with different types of cancer or hematological malignancies: a cross-sectional study.
Int Urol Nephrol. 2024 Dec;56(12):3835-3844. doi: 10.1007/s11255-024-04130-5. Epub 2024 Jun 25.
10
Acute kidney injury prevalence in patients with colorectal cancer undergoing surgery with curative intent.
Contemp Oncol (Pozn). 2022;26(3):187-190. doi: 10.5114/wo.2021.111057. Epub 2021 Nov 24.

本文引用的文献

1
Anticancer Drug-Induced Acute Kidney Injury.
Kidney Int Rep. 2017 Feb 16;2(4):504-514. doi: 10.1016/j.ekir.2017.02.008. eCollection 2017 Jul.
2
Acute Kidney Injury in Hematopoietic Cell Transplantation Patients Receiving Vancomycin and Piperacillin/Tazobactam Versus Vancomycin and Cefepime.
Biol Blood Marrow Transplant. 2018 Apr;24(4):820-826. doi: 10.1016/j.bbmt.2017.12.799. Epub 2017 Dec 29.
3
Acute kidney injury burden in different clinical units: Data from nationwide survey in China.
PLoS One. 2017 Feb 2;12(2):e0171202. doi: 10.1371/journal.pone.0171202. eCollection 2017.
4
A Decision-Making Algorithm for Initiation and Discontinuation of RRT in Severe AKI.
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):228-236. doi: 10.2215/CJN.07170716. Epub 2017 Jan 24.
5
Community-Acquired Acute Kidney Injury: A Nationwide Survey in China.
Am J Kidney Dis. 2017 May;69(5):647-657. doi: 10.1053/j.ajkd.2016.10.034. Epub 2017 Jan 20.
6
The characteristics and mortality risk factors for acute kidney injury in different age groups in China-a cross sectional study.
Ren Fail. 2016 Oct;38(9):1413-1417. doi: 10.1080/0886022X.2016.1227618. Epub 2016 Oct 19.
7
Long-Term Exposure to Air Pollution and Increased Risk of Membranous Nephropathy in China.
J Am Soc Nephrol. 2016 Dec;27(12):3739-3746. doi: 10.1681/ASN.2016010093. Epub 2016 Jun 30.
10
Acute kidney injury in China: a cross-sectional survey.
Lancet. 2015 Oct 10;386(10002):1465-71. doi: 10.1016/S0140-6736(15)00344-X.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验